Obesity and type 2 diabetes: What Can be unified and what needs to be individualized?

Diabetes Care

Volumn 34, Issue 6, 2011, Pages 1424-1430

  Eckel, Robert H ^a   Kahn, Steven E ^b   Ferrannini, Ele ^c   Goldfine, Allison B ^d   Nathan, David M ^e   Schwartz, Michael W ^f   Smith, Robert J ^g   Smith, Steven R ^h  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF PISA   (Italy)

^d HARVARD MEDICAL SCHOOL   (United States)

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^g BROWN UNIVERSITY   (United States)

^h FLORIDA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; ANTIDIABETIC AGENT; ANTIOBESITY AGENT; GLUCOSE; INSULIN; RESISTIN; RETINOL BINDING PROTEIN 4; TUMOR NECROSIS FACTOR ALPHA;

BARIATRIC SURGERY; BEHAVIOR MODIFICATION; CALORIC RESTRICTION; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; DISEASE DURATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DRUG APPROVAL; EATING HABIT; EXERCISE; GASTRIC BANDING; GENE; GENE DELETION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GLUCOSE BLOOD LEVEL; HERITABILITY; HUMAN; HYPERINSULINEMIA; INDIVIDUALIZATION; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; LIPID STORAGE; LOW CARBOHYDRATE DIET; LOW FAT DIET; MEDICAL EXPERT; MEDICAL RESEARCH; MEDICAL SOCIETY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PANCREAS ISLET BETA CELL; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT CARE; PDX1 GENE; ROUX Y ANASTOMOSIS; SURGICAL APPROACH; WEIGHT REDUCTION;

ANIMALS; ANTI-OBESITY AGENTS; BARIATRIC SURGERY; BEHAVIOR THERAPY; DIABETES MELLITUS, TYPE 2; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; OBESITY; RISK FACTORS; WEIGHT LOSS;

EID: 80051965099     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc11-0447     Document Type: Conference Paper

References (50)

1. Centers for Disease Control and Prevention. National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011. Atlanta, GA, U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, 2011
2. Boyle J.P., Thompson T.J., Gregg E.W., Barker L.E., Williamson D.F. Projection of the year 2050 burden of diabetes in the US adult population: Dynamic modeling of incidence, mortality, and prediabetes prevalence. Popul Health Metr 2010;8:29
3. Björntorp P. Metabolic implications of body fat distribution. Diabetes Care 1991;14:1132-1143
4. Cypess A.M., Lehman S., Williams G., et al. Identification and importance of brown adipose tissue in adult humans. N Engl J Med 2009;360:1509-1517
5. Frontini A., Cinti S. Distribution and development of brown adipocytes in the murine and human adipose organ. Cell Metab 2010;11:253-256
6. Deng Y., Scherer P.E. Adipokines as novel biomarkers and regulators of the metabolic syndrome. Ann N Y Acad Sci 2010;1212:E1-E19
7. Larson-Meyer D.E., Newcomer B.R., Ravussin E., et al. Intrahepatic and intramyocellular lipids are determinants of insulin resistance in prepubertal children. Diabetologia 2011;54:869-875
8. Bournat J.C., Brown C.W. Mitochondrial dysfunction in obesity. Curr Opin Endocrinol Diabetes Obes 2010;17:446-452
9. Bagdade J.D., Bierman E.L., Porte D. Jr. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects. J Clin Invest 1967;46:1549-1557
10. Polonsky K.S., Given B.D., Hirsch L., et al. Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest 1988;81:435-441 (Pubitemid 18075237)
11. Klöppel G., Löhr M., Habich K., Oberholzer M., Heitz P.U. Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. Surv Synth Pathol Res 1985;4:110-125
12. Butler A.E., Janson J., Bonner-Weir S., Ritzel R., Rizza R.A., Butler P.C. β-Cell deficit and increased β-cell apoptosis in humans with type 2 diabetes. Diabetes 2003;52:102-110 (Pubitemid 36042113)
13. Kahn S.E., Hull R.L., Utzschneider K.M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 2006;444:840-846 (Pubitemid 46024990)
14. Johnson J.D., Ahmed N.T., Luciani D.S., et al. Increased islet apoptosis in Pdx1+/- mice. J Clin Invest 2003;111:1147-1160 (Pubitemid 36519932)
15. Leibowitz G., Ferber S., Apelqvist A., et al. IPF1/PDX1 deficiency and β-cell dysfunction in Psammomys obesus, an animal with type 2 diabetes. Diabetes 2001;50:1799-1806 (Pubitemid 33641599)
16. Stoffers D.A., Ferrer J., Clarke W.L., Habener J.F. Early-onset type-II diabetes mellitus (MODY4) linked to IPF1. Nat Genet 1997;17:138-139
17. Rampersaud E., Damcott C.M., Fu M., et al. Identification of novel candidate genes for type 2 diabetes from a genome-wide association scan in the Old Order Amish: Evidence for replication from diabetes-related quantitative traits and from independent populations. Diabetes 2007;56:3053-3062 (Pubitemid 350223642)
18. Hayes M.G., Pluzhnikov A., Miyake K., et al. Identification of type 2 diabetes genes in Mexican Americans through genome-wide association studies. Diabetes 2007;56:3033-3044 (Pubitemid 350223640)
19. Scherag A., Dina C., Hinney A., et al. Two new loci for body-weight regulation identified in a joint analysis of genome-wide association studies for early-onset extreme obesity in French and German study groups. PLoS Genet 2010;6:e1000916
20. Lindgren C.M., Heid I.M., Randall J.C., et al.; Wellcome Trust Case Control Consortium; Procardis Consortia; Giant Consortium. Genome-wide association scan meta-analysis identifies three loci influencing adiposity and fat distribution. PLoS Genet 2009;5:e1000508
21. Bogardus C. Missing heritability and GWAS utility.Obesity (Silver Spring) 2009;17:209-210
22. Lander E.S. Initial impact of the sequencing of the human genome. Nature 2011;470:187-197
23. Hotamisligil G.S., Erbay E. Nutrient sensing and inflammation in metabolic diseases. Nat Rev Immunol 2008;8:923-934
24. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112:1796-1808 (Pubitemid 38063703)
25. Obici S., Zhang B.B., Karkanias G., Rossetti L. Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 2002;8:1376-1382 (Pubitemid 36019422)
26. Thaler J.P., Schwartz M.W. Minireview: Inflammation and obesity pathogenesis: Inflammation and obesity pathogenesisThe hypothalamus heats up. Endocrinology 2010;151:4109-4115
27. Calegari V.C., Torsoni A.S., Vanzela E.C., et al. Inflammation of the hypothalamus leads to defective pancreatic islet function. J Biol Chem. 21 January 2011 [Epub ahead of print]
28. Knowler W.C., Barrett-Connor E., Fowler S.E., et al.; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or Metformin. N Engl J Med 2002;346:393-403 (Pubitemid 34437694)
29. Look AHEADResearch Group. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: Fouryear results of the Look AHEAD trial. Arch Intern Med 2010;170:1566-1575
30. Larsen T.M., Dalskov S.M., Van Baak M., et al.; Diet, Obesity, and Genes (Diogenes) Project. Diets with high or low protein content and glycemic index for weight-loss maintenance. N Engl J Med 2010;363:2102-2113
31. Papadaki A., Linardakis M., Larsen T.M., et al.; DiOGenes Study Group. The effect of protein and glycemic index on children's body composition: The DiOGenes randomized study. Pediatrics 2010;126:e1143-e1152
32. Sjöström L., Lindroos A.K., Peltonen M., et al.; Swedish Obese Subjects Study Scientific Group. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004;351:2683-2693 (Pubitemid 39665322)
33. Adams T.D., Gress R.E., Smith S.C., et al. Long-term mortality after gastric bypass surgery. N Engl J Med 2007;357:753-761 (Pubitemid 47295642)
34. Buchwald H., Estok R., Fahrbach K., et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009;122:248-256.e5
35. Sjöström L., Narbro K., Sjöström C.D., et al.; Swedish Obese Subjects Study. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007;357:741-752 (Pubitemid 47295641)
36. Makary M.A., Clarke J.M., Shore A.D., et al. Medication utilization and annual health care costs in patients with type 2 diabetes mellitus before and after bariatric surgery. Arch Surg 2010;145:726-731
37. Vetter M.L., Cardillo S., Rickels M.R., Iqbal N. Narrative review: Effect of bariatric surgery on type 2 diabetesmellitus. Ann Intern Med 2009;150:94-103
38. Korner J., Inabnet W., Febres G., et al. Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass. Int J Obes (Lond) 2009;33:786-795
39. Schauer P.R., Burguera B., Ikramuddin S., et al. Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus. Ann Surg 2003;238:467-484; discussion 84-85
40. Lautz D., Halperin F., Goebel-Fabbri A., Goldfine A.B. The great debate: Medicine or surgery: Medicine or surgeryWhat is best for the patient with type 2 diabetes? Diabetes Care 2011;34:763-770
41. Rigotti N.A. Clinical practice. Treatment of tobacco use and dependence. N Engl J Med 2002;346:506-512 (Pubitemid 34441743)
42. Nathan D.M., Buse J.B., Davidson M.B., et al.; American Diabetes Association; European Association for the Study of Diabetes. Medical management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: A consensus algorithm for the initiation and adjustment of therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2009;32:193-203
43. Kahn S.E., Haffner S.M., Heise M.A., et al.; ADOPT Study Group. Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 2006;355:2427-2443 (Pubitemid 44903747)
44. Smith R.J., Nathan D.M., Arslanian S.A., Groop L., Rizza R.A., Rotter J.I. Individualizing therapies in type 2 diabetes mellitus based on patient characteristics: What we know and what we need to know. J Clin Endocrinol Metab 2010;95:1566-1574
45. Eckel R.H. Clinical practice. Nonsurgical management of obesity in adults. N Engl J Med 2008;358:1941-1950
46. Shai I., Jiang R., Manson J.E., et al. Ethnicity, obesity, and risk of type 2 diabetes in women: A 20-year follow-up study. Diabetes Care 2006;29:1585-1590 (Pubitemid 44127585)
47. Gálvez B.G., San Martín N., Rodríguez C. TNF-a is required for the attraction of mesenchymal precursors to white adipose tissue in ob/ob mice. PLoS ONE 2009;4:e4444
48. Cao Y. Angiogenesis modulates adipogenesis and obesity. J Clin Invest 2007;117:2362-2368 (Pubitemid 47494333)
49. DeFronzo R.A., Tripathy D., Schwenke D.C., et al.; ACT NOW Study. Pioglitazone for diabetes prevention in impaired glucose tolerance. N Engl J Med 2011;364:1104-1115
50. Ryan D.H., Johnson W.D., Myers V.H., et al. Nonsurgical weight loss for extreme obesity in primary care settings: Results of the Louisiana Obese Subjects Study. Arch Intern Med 2010;170:146-154